Transmedics Group Inc Earnings

Transmedics Group Inc’s revenue jumped 48.21% since last year same period to $143.54Mn in the Q1 2025. On a quarterly growth basis, Transmedics Group Inc has generated 18.02% jump in its revenue since last 3-months.

Transmedics Group Inc’s net profit jumped 110.56% since last year same period to $25.68Mn in the Q1 2025. On a quarterly growth basis, Transmedics Group Inc has generated 274.54% jump in its net profits since last 3-months.

Transmedics Group Inc’s net profit margin jumped 42.07% since last year same period to 17.89% in the Q1 2025. On a quarterly growth basis, Transmedics Group Inc has generated 217.36% jump in its net profit margins since last 3-months.

Transmedics Group Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 90.98.

Transmedics Group Inc’s earning per share (EPS) estimates for the current quarter stand at 0.45 - a 84.54% jump from last quarter’s estimates.

Transmedics Group Inc’s earning per share (EPS) estimates for the current year stand at 0.45.

Transmedics Group Inc’s earning per share (EPS) jumped 100% since last year same period to 0.7 in the Q1 2025. This indicates that the Transmedics Group Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Transmedics Group Inc’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Transmedics Group Inc’s return on equity (ROE) stands at 0.23.